glp-1 препараты Пока страховщики борются с расходами на GLP-1, некоторые пытаются отучить пациентов от них : r/EverythingScience Агонисты рецепторов глюканоподобного пептида‑1 и

A recent systemic review and meta-analysis published in the British Medical Journal (BMJ) found that while people tend to lose more weight more quickly with GLP-1s compared to traditional behavioral weight loss programs like exercise and diets, they may gain weight back faster after they stop taking the drugs compared to after they stop these lifestyle changes

Triple agonist or GIP/GLP-1/glucagon receptor agonist is more accurate because the compound does not act on a receptor called GLP-3

In one study, non-diabetic GLP-1 users who maintained stable weights had a 22% higher osteoporosis risk compared to those on other weight loss medications

36 Finally, a cross-sectional study also demonstrated adverse effects of GLP-1 agonists, with patients on exenatide reporting higher PHQ-9 scores (9.70 4.92 vs 6.70 4.66